Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study

被引:16
|
作者
Malagu, Michele [1 ]
Vitali, Francesco [1 ]
Brieda, Alessandro [1 ]
Cimaglia, Paolo [1 ]
De Raffele, Martina [1 ]
Tazzari, Enea [1 ]
Musolino, Cristina [1 ]
Balla, Cristina [1 ]
Serenelli, Matteo [1 ]
Cultrera, Rosario [2 ]
Rapezzi, Claudio [1 ]
Bertini, Matteo [1 ]
机构
[1] S Anna Univ Hosp, Cardiol Ctr, Via Aldo Moro 8, I-44124 Cona Ferrara, Italy
[2] S Anna Univ Hosp, Infect Dis Unit, Ferrara, Italy
来源
EUROPACE | 2022年 / 24卷 / 03期
关键词
Cardiac implantable electronic device; Infection; Antibiotic prophylaxis; Pacemaker; Implantable cardioverter-defibrillator; Shariff score; PREVENTION; PACEMAKER; BIOFILM; RATES; MICROBIOLOGY; PATHOGENESIS; MORTALITY;
D O I
10.1093/europace/euab222
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims In patients undergoing cardiac implantable electronic device (CIED) intervention, routine pre-procedure antibiotic prophylaxis is recommended. A more powerful antibiotic protocol has been suggested in patients at high risk of infection. Stratification of individual infective risk could guide the prophylaxis before CIED procedure. Methods and results Patients undergoing CIED surgery were stratified according to the Shariff score in low and high infective risk. Patients in the 'low-risk' group were treated with only two antibiotic administrations while patients in the 'high-risk' group were treated with a prolonged 9-day protocol, according to renal function and allergies. We followed-up patients for 250 days with clinical outpatient visit and electronic control of the CIED. As primary endpoint, we evaluated CIED-related infections. A total of 937 consecutive patients were enrolled, of whom 735 were stratified in the 'low-risk' group and 202 in the 'high-risk' group. Despite different risk profiles, CIED-related infection rate at 250 days was similar in the two groups (8/735 in 'low risk' vs. 4/202 in 'high risk', P = 0.32). At multivariate analysis, active neoplasia, haematoma, and reintervention were independently associated with CIED-related infection (HR 5.54, 10.77, and 12.15, respectively). Conclusion In a large cohort of patients undergoing CIED procedure, an antibiotic prophylaxis based on individual stratification of infective risk resulted in similar rate of infection between groups at high and low risk of CIED-related infection.
引用
收藏
页码:413 / 420
页数:8
相关论文
共 50 条
  • [41] Risk of Device Malfunction in Cancer Patients with Implantable Cardiac Device Undergoing Radiotherapy: A Population-Based Cohort Study
    Zaremba, Tomas
    Jakobsen, Annette Ross
    Sogaard, Mette
    Thogersen, Anna Margrethe
    Johansen, Martin Berg
    Madsen, Laerke Bruun
    Riahi, Sam
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (03): : 343 - 356
  • [42] Adherent skin barrier drape use is associated with a reduced risk of cardiac implantable device infection: Results from a prospective study of 14,225 procedures
    Golian, Mehrdad
    Berbenetz, Nicolas M.
    Odabashian, Roupen
    Sadek, Mouhannad M.
    Corrales-Medina, Vicente
    Aydin, Alper
    Davis, Darryl R.
    Green, Martin S.
    Klein, Andres
    Nair, Girish M.
    Nery, Pablo B.
    Ramirez, Daniel
    Redpath, Calum
    Hansom, Simon P.
    Birnie, David H.
    HEART RHYTHM, 2024, 5 (02) : 103 - 112
  • [43] Antibiotic Prophylaxis Practices in Pediatric Cardiac Implantable Electronic Device Procedures: A Survey of the Pediatric And Congenital Electrophysiology Society (PACES)
    Chen, Spenser Y.
    Ceresnak, Scott R.
    Motonaga, Kara S.
    Trela, Anthony
    Hanisch, Debra
    Dubin, Anne M.
    PEDIATRIC CARDIOLOGY, 2018, 39 (06) : 1129 - 1133
  • [44] Patient Information Needs and Decision-Making Before a Cardiac Implantable Electronic Device: A Qualitative Study Utilizing Social Media Data
    Nicmanis, Mitchell
    Holmes, Joshua
    Oxlad, Melissa
    Chur-Hansen, Anna
    JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS, 2025, 32 (01) : 121 - 130
  • [45] The Impact of Changing Antiseptic Skin Preparation Agent used for Cardiac Implantable Electronic Device (CIED) Procedures on the Risk of Infection
    Qintar, Mohammed
    Zardkoohi, Omeed
    Hammadah, Muhammad
    Hsu, Amy
    Wazni, Oussama
    Wilkoff, Bruce L.
    Tarakji, Khaldoun G.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (02): : 240 - 246
  • [46] Outcomes in cardiac implantable electronic device-related infective endocarditis: a systematic review of current literature
    Sanghavi, Ria
    Ravikumar, Nidhruv
    Sarodaya, Varun
    Haq, Mawiyah
    Sherif, Mohamed
    Harky, Amer
    FUTURE CARDIOLOGY, 2022, 18 (11) : 891 - 899
  • [47] Surgical extraction of cardiac implantable electronic device leads based on a heart team approach
    Mizuno, Tomohiro
    Goya, Masahiko
    Fujiwara, Tatsuki
    Oishi, Kiyotoshi
    Takeshita, Masashi
    Yashima, Masafumi
    Nagaoka, Eiki
    Oi, Keiji
    Sasano, Tetsuo
    JOURNAL OF CARDIOLOGY, 2023, 81 (01) : 111 - 116
  • [48] Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection
    Calderon-Parra, Jorge
    Sanchez-Chica, Enrique
    Asensio-Vegas, Angel
    Fernandez-Lozano, Ignacio
    Toquero-Ramos, Jorge
    Castro-Urda, Victor
    Royuela-Vicente, Ana
    Ramos-Martinez, Antonio
    REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (10): : 806 - 812
  • [49] Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis
    Koerber, Scott M.
    Turagam, Mohit K.
    Winterfield, Jeffery
    Gautam, Sandeep
    Gold, Michael R.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2018, 29 (04) : 609 - 615
  • [50] The management of cardiac implantable electronic device lead perforations: a multicentre study
    Acha, Moshe Rav
    Rafael, Allon
    Keaney, John J.
    Elitzur, Yair
    Danon, Asaf
    Shauer, Ayelet
    Taha, Louay
    Shechter, Yonat
    Bogot, Naama R.
    Luria, David
    Ilan, Michael
    Singh, Sheldon M.
    Mela, Theofanie
    Weisz, Giora
    Glikson, Michael
    Medina, Aharon
    EUROPACE, 2019, 21 (06): : 937 - 943